Following an acute 4 hour treatment with the reducing agent DTT, all glioma lines demonstrated a marked induction of XBP-1, BiP/GRP78, and CHOP mRNAs, while maintaining steady levels of GAPDH message (Figure 4A). The gene discussed is DDIT3; the disease is central nervous system cancer.